Evidence map›Paper›PMID 32382282›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2020

Rongmei Yao, Zihan Geng, Xin Mao, Yanyan Bao, Shanshan Guo, Lei Bao, Jing Sun, Yingjie Gao, Yingli Xu, Bo Guo and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Effects of evodiamine on ROS/TXNIP/NLRP3 pathway against gouty arthritis.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Investigation of the Effects and Mechanisms ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Rongmei YaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID https://orcid.org/0000-0003-3355-2533
Zihan GengInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Xin MaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID https://orcid.org/0000-0002-8873-2120
Yanyan BaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Shanshan GuoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Lei BaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID https://orcid.org/0000-0002-9536-9091
Jing SunInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID https://orcid.org/0000-0001-7653-9481
Yingjie GaoInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Yingli XuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID https://orcid.org/0000-0002-8933-3420
Bo GuoDepartment of Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou 450003, China.
Fengxian MengDongfang Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China.ORCID https://orcid.org/0000-0002-8038-3210
Xiaolan CuiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.ORCID https://orcid.org/0000-0003-4023-6424
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBeijing University of Chinese Medicine · CNHenan Provincial People's Hospital · CNNorth China University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gouty arthritis is an inflammatory joint disease closely related to hyperuricemia. It is characterized by deposition of monosodium urate crystals in the joints, resulting in an intense inflammatory process and pain. Control of hyperuricemia and anti-inflammation treatments are the main therapeutic approaches. However, the commonly used drugs for inhibiting uric acid and acute gouty arthritis have obvious gastrointestinal and renal toxicity; thus, there is an urgency to develop new alternative therapeutic drugs. An extract of

Identifiers

PMID32382282
PMCPMC7193269
OpenAlexW3018515092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.